IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 265 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $640,000 | +49.9% | 13,786 | +6.5% | 0.00% | +50.0% |
| Q3 2020 | $427,000 | +52.0% | 12,946 | +26.3% | 0.00% | 0.0% |
| Q2 2020 | $281,000 | -4.4% | 10,249 | +4.3% | 0.00% | 0.0% |
| Q1 2020 | $294,000 | -3.3% | 9,829 | -10.6% | 0.00% | +100.0% |
| Q4 2019 | $304,000 | +52.0% | 11,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $200,000 | -25.9% | 11,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $270,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |